On April 3, 2025, EU Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion on Hydroxyapatite (CAS No. 1306-06-17) in nano form, following the industry's fourth submission of a safety assessment dossier for the ingredient. Comments are invited until May 30, 2025.1